Lounis, M.; Aouissi, H.A.; Abdelhadi, S.; Rais, M.A.; Belkessa, S.; Bencherit, D.
Short-Term Adverse Effects Following Booster Dose of Inactivated-Virus vs. Adenoviral-Vector COVID-19 Vaccines in Algeria: A Cross-Sectional Study of the General Population. Vaccines 2022, 10, 1781.
https://doi.org/10.3390/vaccines10111781
AMA Style
Lounis M, Aouissi HA, Abdelhadi S, Rais MA, Belkessa S, Bencherit D.
Short-Term Adverse Effects Following Booster Dose of Inactivated-Virus vs. Adenoviral-Vector COVID-19 Vaccines in Algeria: A Cross-Sectional Study of the General Population. Vaccines. 2022; 10(11):1781.
https://doi.org/10.3390/vaccines10111781
Chicago/Turabian Style
Lounis, Mohamed, Hani Amir Aouissi, Samir Abdelhadi, Mohammed Amir Rais, Salem Belkessa, and Djihad Bencherit.
2022. "Short-Term Adverse Effects Following Booster Dose of Inactivated-Virus vs. Adenoviral-Vector COVID-19 Vaccines in Algeria: A Cross-Sectional Study of the General Population" Vaccines 10, no. 11: 1781.
https://doi.org/10.3390/vaccines10111781
APA Style
Lounis, M., Aouissi, H. A., Abdelhadi, S., Rais, M. A., Belkessa, S., & Bencherit, D.
(2022). Short-Term Adverse Effects Following Booster Dose of Inactivated-Virus vs. Adenoviral-Vector COVID-19 Vaccines in Algeria: A Cross-Sectional Study of the General Population. Vaccines, 10(11), 1781.
https://doi.org/10.3390/vaccines10111781